期刊文献+

IL-18基因导入对小鼠胶原诱导关节炎作用的研究

下载PDF
导出
摘要 目的观察IL-18基因导入对小鼠胶原诱导性关节炎(CIA)的治疗作用。方法在CIA小鼠发病早期,将IL-18表达质粒pCAGGS-IL-18(pIL-18)经肌肉注射导入CIA小鼠体内,对照组给予空白质粒pCAGGS,3周后同量加强治疗1次。用关节炎评分评估CIA小鼠的病情,用组织学染色评价膝关节的软骨和骨破坏,用RT-PCR和real-time PCR法测定CIA小鼠髌骨及邻近滑膜组织的细胞因子及转录因子表达水平。结果与对照组相比,治疗组能有效抑制胶原诱导性关节炎小鼠的关节炎评分,阻止关节软骨破坏,虽然髌骨及邻近的滑膜组织IL-18的mRNA表达没有明显改变,但TNF-α及IL-17A的mRNA表达明显降低,IL-10的mRNA表达明显增加,同时,Th2型转录因子GATA-3的表达明显增高,Th2型转录因子T-bet及Th17型转录因子ROR-γt的表达无明显改变。结论与IL-18的细胞因子治疗不同,单独IL-18表达质粒的基因导入即可对CIA小鼠达到治疗作用。该作用通过提高GATA-3的表达,增加Th2型细胞因子IL-10,降低Th1型细胞因子TNF-α及Th17型细胞因子IL-17A的表达来实现。 Objective To investigate the effect of IL-18 gene therapy on murine collagen-induced arthritis(CIA). Method CIA mice were injected with IL-18-expressing plasmid pCAGGS-IL-18(pIL-18)intramuscularly(i.m). A booster injection was given with the same dosage in three weeks. Control group were injected with pCAGGS at the same dosage. The arthritis response was monitored visually by macroscopic scoring. Histology of knee was performed to assess the occurrence of cartilage destruction and bone erosion. RT-PCR(reverse transcription-polymerase chain reaction)and real-time PCR were employed to determine the mRNA expression of cytokine and transcription factors in patella with adjacent synovium in CIA mouse. Results Compared with control group,treatment groups showed a remission on macroscopic score and advancement of histology. Moreover,the mRNA levels of IL-17A and TNF-α,but not IL-10,were greatly inhibited both in the synovial tissue and in the articular cartilage in treatment group. Further analysis in the mechanism indicated that the expression of GATA-3 was significantly higher than that of T-bet and ROR-γt. Conclusion These data indicated that gene transfer of IL-18 suppressed the macroscopic score of CIA,which may be mediated not only by inhibiting inflammatory cytokines such as IL-17A and TNF-α,but also by inducing anti-inflammatory mediators such as IL-10. Moreover,the transcription factor of GATA-3 may play an important role on it.
出处 《浙江临床医学》 2014年第6期856-858,869,共4页 Zhejiang Clinical Medical Journal
基金 国家自然科学基金项目编号(30600561)
关键词 胶原诱导性关节炎 白细胞介素-18 基因治疗 Collagen induced arthritis IL-I 8 Gene therapy
  • 相关文献

参考文献11

  • 1Vervoordeldonk MJ,Tak PP.Cytokines in rheumatoid arthritis.Curt ILheumatol ILep,2002,4:208-217.
  • 2Ivanov Ⅱ,McKenzie BS,Zhou L,et al.The orphan nuclear receptor ROiLgammat directs the differentiation program of pro-inflammatory IL-17+ T helper cells,Cell,2006,T 126:1121-133.
  • 3Dinarello Charles.Alnterleukin-1 and interleukin-18 as mediators of inflammation and the aging process. AmJ Clin Nutr,2006,83:447S-455S.
  • 4Veenbergen S,Smeets ILL.The natural soluble form oflL-18 receptor 13 exacerbates collagen-induced arthritis via modulation ofT-cell immune responses.Ann Rheum Dis,2010,69:276-283.
  • 5代巧姝,张凤山,李洋.小剂量白细胞介素-18对胶原诱导性关节炎作用的研究[J].中华风湿病学杂志,2009,13(8):535-538. 被引量:5
  • 6Smeets RL,Loo FAJ van de,Arntz OJ.Adenoviral delivery of IL-18BPC ameliorates CIA in mice.Gene Therapy,2003,10:1004-1011.
  • 7Kawashima M,Missec P,mRNA quantification of T-bet,GATA-3, IFN-gamma,and IL-4 shows a defective Thl immune response in the peripheral blood from rheumatoid arthritis patients: link with disease activiW. J Clin Immunol,2005,3:209-214.
  • 8Nistala K,Wedderbum LR,Thl7 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis.Rheumatology, 2009,6:602-606.
  • 9Charbonnier LM, Han WGH, Quentin J, et al. Adoptive transfer of IL- 10-secreting CD4^+CD49b^+ regulatory T cells suppresses ongoing arthritis. Journal of Autoimmunity,2009,34: 390-399.
  • 10Cho ML.Interleukin-18 induces the production of vascular endothelial grwth facto r(VE GF) in rheumatoid arthritis synovial fivroblasts via AP - 1 - dependent pathways,Immunol Lett,2006,103:159-166.

二级参考文献10

  • 1Vervoordeldonk M J, Tak PP. Cytokines in rheumatoid arthritis Curr Rheumatol Rep, 2002, 4: 208-217.
  • 2Ye XJ, Tang B, Ma Z. The roles of interleukin-18 in collagen- induced arthritis in the BB rat. Clin Exp Immunol, 2004, 136: 440-447.
  • 3Xu D, Trajkovic V, Hunter D, et al. Trajkovic IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur J Immunol, 2000, 30: 3147-3156.
  • 4Tak PP, Bacchi M, Bertolino M. Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. Eur J Drug Metab Pharm-acokinet, 2006, 31: 109-116.
  • 5Okamoto Y, Nishida M. Cytokine balance in the pathogenesis of rheumatoid arthritis. Yakugaku Zasshi, 2001, 121: 131-138.
  • 6Nakanishi K, Yoshimoto T, Tsutsui H, et al. Interleukin-18 regulates both Th1 and Th2 responses. Ann Rev Immunol, 2001,19: 423-474.
  • 7Joosten LA, Radstake TR, Lubherts E, et al. Association of interleukin-18 expression with enhanced levels of both interleukin-1 beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum, 2003, 48: 339-347.
  • 8Cho ML. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial flbroblasts via AP-l-dependent pathways. Immunol Lett, 2006,103: 159-166.
  • 9Charles A, Dinarello MD. lnterleukin-18 and the treatment of rheumatoid arthritis. Rheum Dis Clin North Am, 2004, 30: 417-434.
  • 10McInnes IB, Liew FY, Gracie JA. IL-18: a therapeutic target in rheumatoid arthritis. Arthritis Res Ther, 2005, 7: 38-41.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部